Condition
Arteriovenous Fistula Occlusion
Total Trials
5
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Unknown1
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07559942Not ApplicableRecruiting
Effect of Apiban Therapy on AVF Maturation in ESRD Patients
NCT04543539Active Not Recruiting
IN.PACT™ AV Access Post-Approval Study (PAS002)
NCT03041467Not ApplicableCompleted
IN.PACT™ AV Access IDE Study
NCT05832476CompletedPrimary
O-GlcNac Modified Proteomics Study of the Maturation of Hemodialysis Arteriovenous
NCT03106948Phase 2UnknownPrimary
Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis
Showing all 5 trials